Recent Advances in the Treatment of Alopecia Areata - Episode 13
Real-World Clinical Experience With JAK Inhibitors
Published on:
Panelists discuss their clinical experiences with Janus kinase (JAK) inhibitors for treating alopecia, noting observed differences in outcomes and tolerability among various systemic JAK inhibitors, while highlighting the advantages of these therapies over traditional local and systemic treatment options.
Video content above is prompted by the following:
What has been your clinical experience with JAK inhibitors for treatment of alopecia?
a. Have you observed differences in outcomes and/or tolerability with using different systemic JAK inhibitors?
What are the advantages of using systemic JAK inhibitor therapies compared with traditional local or systemic therapies?
